Literature DB >> 9764614

Sequence analysis of V(4-34)-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE).

C I Mockridge1, C J Chapman, M B Spellerberg, B Sheth, T P Fleming, D A Isenberg, F K Stevenson.   

Abstract

SLE is an autoimmune disease characterized by the presence of autoantibodies against double-stranded (ds)DNA. A large proportion (approx. 40%) of patients with lupus also have increased levels of serum immunoglobulin encoded by the V(4-34) heavy chain gene, which often fluctuate with disease activity, and this gene is utilized by a subset of anti-dsDNA antibodies. In order to probe the nature of the V(4-34)-encoded immunoglobulin, B cells were isolated from the blood of two patients with active disease, using the 9G4 MoAb specific for the immunoglobulin gene product. Following cell picking, single-cell polymerase chain reaction (PCR) amplification of cDNA was used to investigate both V(H) and V(L) genes. Sequences were obtained from B cells synthesizing IgM (n = 10), IgG (n = 4) and IgA (n = 1). For V(H), all were derived from V(4-34) as expected, and the isotype-switched sequences and 2/6 IgM sequences were somatically mutated. In contrast, V(L) (12 kappa and 3 lambda) showed a low level of mutation, possibly indicating secondary rearrangements. The three most highly mutated V(H) sequences were associated with unmutated V(L) sequences. Analysis of the distribution of mutations revealed only minor clustering in complementarity-determining regions (CDRs) characteristic of antigen selection. The CDR3 lengths of V(H) ranged from five to 19 amino acids, and in 3/15 there was evidence of an excess of positively charged amino acids, compared with the normal expressed repertoire. Basic amino acids were also found at the V(L)-J(L) junctions in 4/15. These findings provide insight into the V(4-34)-V(L) gene combinations used by B cells in patients with SLE which might have clinical relevance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764614      PMCID: PMC1905086          DOI: 10.1046/j.1365-2249.1998.00703.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection.

Authors:  C J Chapman; J X Zhou; C Gregory; A B Rickinson; F K Stevenson
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

Review 2.  The human immunoglobulin VH repertoire.

Authors:  G P Cook; I M Tomlinson
Journal:  Immunol Today       Date:  1995-05

3.  Specific mRNA detection in single lineage-marked blastomeres from preimplantation embryos.

Authors:  J Collins; T Fleming
Journal:  Trends Genet       Date:  1995-01       Impact factor: 11.639

4.  Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II.

Authors:  N M Bhat; M M Bieber; F J Hsu; C J Chapman; M Spellerberg; F K Stevenson; N N Teng
Journal:  Clin Exp Immunol       Date:  1997-04       Impact factor: 4.330

5.  Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.

Authors:  L Spatz; A Iliev; V Saenko; L Jones; M Irigoyen; A Manheimer-Lory; B Gaynor; C Putterman; M Bynoe; C Kowal; P Kuo; J Newman; B Diamond
Journal:  Methods       Date:  1997-01       Impact factor: 3.608

6.  Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

Authors:  S S Sahota; R Leo; T J Hamblin; F K Stevenson
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

7.  Evidence for a large compartment of IgM-expressing memory B cells in humans.

Authors:  U Klein; R Küppers; K Rajewsky
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope.

Authors:  C I Mockridge; C J Chapman; M B Spellerberg; D A Isenberg; F K Stevenson
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

9.  The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3.

Authors:  Y Li; M B Spellerberg; F K Stevenson; J D Capra; K N Potter
Journal:  J Mol Biol       Date:  1996-03-01       Impact factor: 5.469

10.  Pattern of usage of the VH4-21 gene by B lymphocytes in a patient with EBV infection indicates ongoing mutation and class switching.

Authors:  C J Chapman; M B Spellerberg; T J Hamblin; F K Stevenson
Journal:  Mol Immunol       Date:  1995-04       Impact factor: 4.407

View more
  5 in total

1.  Use of the VH6-1 gene segment to code for anti-interleukin-18 autoantibodies in multiple sclerosis.

Authors:  Marina Tiumentseva; Vera Morozova; Aleksandr Zakabunin; Denis Korobko; Nadezhda Malkova; Maksim Filipenko; Nina Tikunova
Journal:  Immunogenetics       Date:  2016-01-07       Impact factor: 2.846

Review 2.  Antibody repertoire analysis in polygenic autoimmune diseases.

Authors:  Rachael J M Bashford-Rogers; Kenneth G C Smith; David C Thomas
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

3.  Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis.

Authors:  Linda M Slot; Rochelle D Vergroesen; Priscilla F Kerkman; Ellen Staudinger; Sanne Reijm; Hugo J van Dooren; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes; Hans U Scherer
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

4.  Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome.

Authors:  Shelly Pathak; Dorota Rowczenio; Samuel Lara-Reyna; Mark Kacar; Roger Owen; Gina Doody; Karoline Krause; Helen Lachmann; Rainer Doffinger; Darren Newton; Sinisa Savic
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

5.  Short-term assessment of BCR repertoires of SLE patients after high dose glucocorticoid therapy with high-throughput sequencing.

Authors:  Bin Shi; Jiang Yu; Long Ma; Qingqing Ma; Chunmei Liu; Suhong Sun; Rui Ma; Xinsheng Yao
Journal:  Springerplus       Date:  2016-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.